Impact Award - Chordoma Foundation supports researchers pursuing preclinical and translational chordoma immunology studies to accelerate research into innovative immunotherapy approaches.
CRI Clinical Innovator supports academic researchers leading early-phase cancer immunotherapy trials to test novel treatments, study response mechanisms, and identify biomarkers to improve patient outcomes.
CRI Impact Grant supports researchers conducting clinically relevant chordoma research that bridges laboratory and clinical discovery to translate immunological findings into cancer immunotherapies.
CRI Technology Impact Award supports technology developers and clinical cancer immunologists in creating unbuilt, untested technologies to overcome barriers and enable more effective cancer immunotherapies.
Clinical Research Investigator-Initiated Awards support junior and senior researchers studying questions in inflammatory bowel disease care, with the aim of generating findings that could change clinical practice.